{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6013",
      "entity_text" : "testosterone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Overall, the AACE and ACE do acknowledge that there are concerns that TRT could increase CV events, especially in those with pre-existing disease and that the benefits of TRT are most consistent in men with very low testosterone levels.",
  "reading_complete" : "2020-08-04T11:42:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:41:47Z",
  "trigger" : "levels",
  "evidence" : [ "testosterone levels" ],
  "pmc_id" : "5182241",
  "score" : 0
}